Exact Sciences CEO Sees Steady Uptick in Cologuard Orders

The transcript discusses the positive reception and validation of a cancer screening test, Cologuard, by major institutions like the Mayo Clinic and FDA. Despite some critics, the company reports significant revenue growth and is focused on engaging more physicians and educating the public. The transcript also addresses concerns about scalability and refutes claims that doctors are not ordering more tests, highlighting a steady increase in orders.

What evidence supports the effectiveness of the Cologuard test?

How has the revenue growth for the company been described?

Discuss the impact of the sales force and marketing on the ordering behavior of doctors regarding Cologuard.

What challenges does the company face in increasing the number of Cologuard tests ordered by physicians?

What is the significance of the major evidence-based guidelines mentioned in the text?